EE411 Cost-Effectiveness of Venetoclax in Combination with Azacitidine in Unfit Patients With Previously Untreated Acute Myeloid Leukemia in China

Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.707
https://www.valueinhealthjournal.com/article/S1098-3015(24)00822-2/fulltext
Section Title :
Section Order : 10176
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00822-2&doi=10.1016/j.jval.2024.03.707
HEOR Topics :
Tags :
Regions :